07:39 AM EDT, 08/18/2025 (MT Newswires) -- Labcorp Holdings ( LH ) said Monday that Lumipulse, the first blood test cleared by the US Food and Drug Administration to help diagnose Alzheimer's disease, is now available nationwide.

The test offers results that are comparable to existing methods, but is less invasive and more affordable and accessible, the company said.

Lumipulse is intended for adults aged 50 years and older with symptoms of cognitive decline, Labcorp ( LH ) said.